is semaglutide being taken off the market for compounded GLP-1 drugs remained robust despite the end of (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with Semaglutide Market Size, Share, Trends,

A five-year longitudinal cohort study reported that semaglutide exposure doubled the risk of NAION, whereas another study found no increased risk

The market is growing rapidly due to high demand for diabetes and weight management treatments, leading to increased competition among brands

Studies showed a remarkable effect on people with obesity: The SELECT Trial found that MACE (major adverse CVD event) risk was reduced by 20% in adults with obesity without T2D in the group taking semaglutide

Recent evidence has shown that the introduction of electrophiles into the cell can alter enzyme activity by quenching lysine and cysteine reactivity (Wang et al, 2014)